Issues regarding 'immortal time' in the analysis of the treatment effects in observational studies.
about
Racial Differences in Association of Serum Calcium with Mortality and Incident Cardio- and Cerebrovascular Events.The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients.Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study.High-dose therapy and autologous stem cell transplant in older adults with multiple myeloma.Does Higher Spending Improve Survival Outcomes for Myocardial Infarction? Examining the Cost-Outcomes Relationship Using Time-Varying CovariatesAssociation of incident restless legs syndrome with outcomes in a large cohort of US veteransMortality in chronic kidney disease and renal replacement therapy: a population-based cohort study.Dialyzer reuse and mortality risk in patients with end-stage renal disease: a systematic review.Comparison of Statistical Approaches for Dealing With Immortal Time Bias in Drug Effectiveness Studies.Synergistic association of combined glycemic and blood pressure level with risk of complications in US veterans with diabetes.Pharmacotherapy Choice Is Associated with 2-Year Mortality for Patients with Heart Failure and Reduced Ejection Fraction.Use of the landmark method to address immortal person-time bias in comparative effectiveness research: a simulation study.
P2860
Q30275940-81F6D897-9954-4880-8C88-DF00386DA569Q33768117-42816DD4-8979-4DA1-AD95-98766C2A8648Q34503008-C9D5CD60-44AA-4BAB-BBBB-09844F85493AQ35920754-077D6110-80E8-4860-B7D9-583F3B136325Q36144455-B43B6CFF-369B-40C5-B780-6BE7CD9F470AQ36698149-319C7AEA-E19A-4DF3-8DB4-BECDAC72865DQ37598037-98F7B808-A4AA-4600-B394-1FE68ADC6839Q37986995-06A6C608-6347-457A-8886-7AD23A797331Q39562024-4016F5C9-B007-4A81-A227-91061B21C1CFQ39958676-7D6DB4E7-01CB-4F7D-9E65-58A90D9AD6C8Q47614022-35F0407F-88C5-4B39-B46D-0C1B1EF503EEQ53210801-ABCE8446-7818-42BD-9147-894393F8698A
P2860
Issues regarding 'immortal time' in the analysis of the treatment effects in observational studies.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Issues regarding 'immortal tim ...... ects in observational studies.
@en
Issues regarding 'immortal tim ...... ects in observational studies.
@nl
type
label
Issues regarding 'immortal tim ...... ects in observational studies.
@en
Issues regarding 'immortal tim ...... ects in observational studies.
@nl
prefLabel
Issues regarding 'immortal tim ...... ects in observational studies.
@en
Issues regarding 'immortal tim ...... ects in observational studies.
@nl
P2093
P356
P1433
P1476
Issues regarding 'immortal tim ...... fects in observational studies
@en
P2093
Allan J Collins
David T Gilbertson
Eric D Weinhandl
Jiannong Liu
P2888
P304
P356
10.1038/KI.2011.388
P407
P577
2011-11-16T00:00:00Z